Manhattan Scientifics, Inc. (MHTX)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -1.16 Million USD | 75.53% |
| 2022 | -4.76 Million USD | -29.88% |
| 2021 | -3.66 Million USD | -184.96% |
| 2020 | 4.31 Million USD | 451.59% |
| 2019 | -1.22 Million USD | 85.28% |
| 2018 | -8.33 Million USD | -639.07% |
| 2017 | 1.54 Million USD | 125.31% |
| 2016 | -6.1 Million USD | -176.24% |
| 2015 | 8.01 Million USD | 310.57% |
| 2014 | -3.8 Million USD | -97.35% |
| 2013 | -1.92 Million USD | 7.75% |
| 2012 | -2.09 Million USD | 8.61% |
| 2011 | -2.28 Million USD | -5218.6% |
| 2010 | -43 Thousand USD | 90.36% |
| 2009 | -446 Thousand USD | 79.18% |
| 2008 | -2.14 Million USD | 28.93% |
| 2007 | -3.01 Million USD | -77.92% |
| 2006 | -1.69 Million USD | -673.52% |
| 2005 | -219 Thousand USD | 85.56% |
| 2004 | -1.51 Million USD | 40.95% |
| 2003 | -2.56 Million USD | 36.22% |
| 2002 | -4.02 Million USD | 39.54% |
| 2001 | -6.66 Million USD | -40.67% |
| 2000 | -4.73 Million USD | 51.67% |
| 1999 | -9.8 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -158 Thousand USD | 58.64% |
| 2024 Q1 | -382 Thousand USD | -50.39% |
| 2023 Q4 | -254 Thousand USD | 3.05% |
| 2023 Q1 | -654 Thousand USD | -6.0% |
| 2023 Q3 | -262 Thousand USD | -14.41% |
| 2023 Q2 | -229 Thousand USD | 64.98% |
| 2023 FY | -1.16 Million USD | 75.53% |
| 2022 Q4 | -617 Thousand USD | -1969.7% |
| 2022 Q1 | -1.11 Million USD | -3167.65% |
| 2022 FY | -4.76 Million USD | -29.88% |
| 2022 Q2 | -3.07 Million USD | -177.05% |
| 2022 Q3 | 33 Thousand USD | 101.07% |
| 2021 Q1 | 134 Thousand USD | -95.14% |
| 2021 Q3 | -1.15 Million USD | 55.25% |
| 2021 Q2 | -2.58 Million USD | -2027.61% |
| 2021 FY | -3.66 Million USD | -184.96% |
| 2021 Q4 | -34 Thousand USD | 97.06% |
| 2020 Q2 | 528 Thousand USD | 172.13% |
| 2020 Q1 | -732 Thousand USD | 33.88% |
| 2020 Q4 | 2.75 Million USD | 56.56% |
| 2020 FY | 4.31 Million USD | 451.59% |
| 2020 Q3 | 1.76 Million USD | 233.52% |
| 2019 FY | -1.22 Million USD | 85.28% |
| 2019 Q4 | -1.1 Million USD | -190.07% |
| 2019 Q3 | 1.22 Million USD | 235.35% |
| 2019 Q2 | -908 Thousand USD | -108.26% |
| 2019 Q1 | -436 Thousand USD | 87.95% |
| 2018 Q4 | -3.61 Million USD | -1216.36% |
| 2018 FY | -8.33 Million USD | -639.07% |
| 2018 Q3 | 324 Thousand USD | 123.63% |
| 2018 Q2 | -1.37 Million USD | 51.52% |
| 2018 Q1 | -2.82 Million USD | -267.04% |
| 2017 Q4 | 1.69 Million USD | 377.54% |
| 2017 FY | 1.54 Million USD | 125.31% |
| 2017 Q3 | -610 Thousand USD | -128.81% |
| 2017 Q2 | 2.11 Million USD | 279.1% |
| 2017 Q1 | -1.18 Million USD | -53.31% |
| 2016 Q4 | -771 Thousand USD | 43.02% |
| 2016 Q1 | -1.89 Million USD | -33.99% |
| 2016 FY | -6.1 Million USD | -176.24% |
| 2016 Q2 | -2.09 Million USD | -10.28% |
| 2016 Q3 | -1.35 Million USD | 35.29% |
| 2015 FY | 8.01 Million USD | 310.57% |
| 2015 Q4 | -1.41 Million USD | 32.23% |
| 2015 Q3 | -2.08 Million USD | -3.93% |
| 2015 Q2 | -2 Million USD | -114.86% |
| 2015 Q1 | 13.52 Million USD | 1667.09% |
| 2014 FY | -3.8 Million USD | -97.35% |
| 2014 Q4 | -863 Thousand USD | -12.96% |
| 2014 Q3 | -764 Thousand USD | 27.45% |
| 2014 Q1 | -1.12 Million USD | -176.53% |
| 2014 Q2 | -1.05 Million USD | 6.4% |
| 2013 Q4 | 1.47 Million USD | 150.79% |
| 2013 Q3 | -2.89 Million USD | -411.31% |
| 2013 Q2 | -566 Thousand USD | -1012.9% |
| 2013 Q1 | 62 Thousand USD | 112.84% |
| 2013 FY | -1.92 Million USD | 7.75% |
| 2012 Q4 | -483 Thousand USD | -49.07% |
| 2012 Q2 | -689 Thousand USD | -15.99% |
| 2012 Q1 | -594 Thousand USD | -25.85% |
| 2012 FY | -2.09 Million USD | 8.61% |
| 2012 Q3 | -324 Thousand USD | 52.98% |
| 2011 FY | -2.28 Million USD | -5218.6% |
| 2011 Q4 | -472 Thousand USD | 55.68% |
| 2011 Q2 | -450 Thousand USD | -50.0% |
| 2011 Q3 | -1.06 Million USD | -136.67% |
| 2011 Q1 | -300 Thousand USD | -139.37% |
| 2010 FY | -43 Thousand USD | 90.36% |
| 2010 Q4 | 762 Thousand USD | 325.44% |
| 2010 Q2 | -313 Thousand USD | -63.02% |
| 2010 Q3 | -338 Thousand USD | -7.99% |
| 2010 Q1 | -192 Thousand USD | 76.0% |
| 2009 Q2 | -209 Thousand USD | 37.24% |
| 2009 Q1 | -333 Thousand USD | -18.51% |
| 2009 FY | -446 Thousand USD | 79.18% |
| 2009 Q3 | 354 Thousand USD | 269.38% |
| 2009 Q4 | -800 Thousand USD | -325.99% |
| 2008 Q1 | -1.25 Million USD | 22.68% |
| 2008 Q3 | -302 Thousand USD | 1.95% |
| 2008 FY | -2.14 Million USD | 28.93% |
| 2008 Q4 | -281 Thousand USD | 6.95% |
| 2008 Q2 | -308 Thousand USD | 75.38% |
| 2007 Q3 | -387 Thousand USD | 48.47% |
| 2007 FY | -3.01 Million USD | -77.92% |
| 2007 Q4 | -1.61 Million USD | -318.09% |
| 2007 Q2 | -751 Thousand USD | -191.09% |
| 2007 Q1 | -258 Thousand USD | -2050.0% |
| 2006 Q3 | -262 Thousand USD | 75.24% |
| 2006 Q4 | -12 Thousand USD | 95.42% |
| 2006 Q2 | -1.05 Million USD | -192.27% |
| 2006 FY | -1.69 Million USD | -673.52% |
| 2006 Q1 | -362 Thousand USD | -166.79% |
| 2005 FY | -219 Thousand USD | 85.56% |
| 2005 Q1 | -104 Thousand USD | 88.18% |
| 2005 Q2 | -369 Thousand USD | -254.81% |
| 2005 Q3 | -288 Thousand USD | 21.95% |
| 2005 Q4 | 542 Thousand USD | 288.19% |
| 2004 Q2 | -20 Thousand USD | 89.58% |
| 2004 Q4 | -880 Thousand USD | -107.06% |
| 2004 Q1 | -192 Thousand USD | 75.19% |
| 2004 FY | -1.51 Million USD | 40.95% |
| 2004 Q3 | -425 Thousand USD | -2025.0% |
| 2003 Q1 | -540 Thousand USD | 60.03% |
| 2003 FY | -2.56 Million USD | 36.22% |
| 2003 Q4 | -774 Thousand USD | -134.55% |
| 2003 Q3 | -330 Thousand USD | 63.5% |
| 2003 Q2 | -904 Thousand USD | -67.41% |
| 2002 Q4 | -1.35 Million USD | -158.32% |
| 2002 FY | -4.02 Million USD | 39.54% |
| 2002 Q2 | -627 Thousand USD | 58.94% |
| 2002 Q1 | -1.52 Million USD | -33.13% |
| 2002 Q3 | -523 Thousand USD | 16.59% |
| 2001 Q1 | -2.03 Million USD | -41.31% |
| 2001 FY | -6.66 Million USD | -40.67% |
| 2001 Q4 | -1.14 Million USD | -3.15% |
| 2001 Q3 | -1.11 Million USD | 53.1% |
| 2001 Q2 | -2.37 Million USD | -16.68% |
| 2000 Q3 | -1.26 Million USD | -19.83% |
| 2000 Q4 | -1.43 Million USD | -13.86% |
| 2000 Q1 | -981 Thousand USD | 0.0% |
| 2000 FY | -4.73 Million USD | 51.67% |
| 2000 Q2 | -1.05 Million USD | -7.44% |
| 1999 FY | -9.8 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| CVR Medical Corp. | - USD | Infinity% |
| BioElectronics Corporation | -722.81 Thousand USD | -61.176% |
| IR-Med Inc. | -4.9 Million USD | 76.268% |
| Polarean Imaging plc | -11.88 Million USD | 90.198% |
| Medical Supply International USA, Inc. | 394.84 Thousand USD | 395.056% |
| Avitar, Inc. | -2.25 Million USD | 48.443% |
| AVITA Medical, Inc. | -39.16 Million USD | 97.026% |
| Össur hf. | 58.38 Million USD | 101.995% |
| Zecotek Photonics Inc. | -3.51 Million USD | 66.894% |
| QHSLab, Inc. | -468.36 Thousand USD | -148.739% |
| Wellstar International, Inc. | -3.1 Million USD | 62.522% |
| Össur hf. | 58.38 Million USD | 101.995% |
| Bionovate Technologies Corp | - USD | Infinity% |
| EKF Diagnostics Holdings plc | 2.35 Million USD | 149.532% |
| Escalon Medical Corp. | -125.26 Thousand USD | -830.058% |
| Aurora Spine Corporation | -1.68 Million USD | 30.678% |
| BrainsWay Ltd. | -4.19 Million USD | 72.242% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| NewCardio, Inc. | -11.49 Million USD | 89.866% |
| Hamilton Thorne Ltd. | -607.02 Thousand USD | -91.921% |
| Vivos Inc. | -2.89 Million USD | 59.755% |
| MicroPort Scientific Corporation | -477.62 Million USD | 99.756% |
| Kelyniam Global, Inc. | -218.47 Thousand USD | -433.252% |
| REMSleep Holdings, Inc. | -1.77 Million USD | 34.471% |
| CYduct Diagnostics, Inc. | -418.03 Thousand USD | -178.686% |
| Nanomix Corporation | -12.33 Million USD | 90.554% |
| Theraclion SA | -3.67 Million USD | 68.299% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Wellness Center USA, Inc. | -752.98 Thousand USD | -54.718% |
| Positron Corporation | -1.63 Million USD | 28.907% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | -2.64 Million USD | 55.892% |
| Lombard Medical, Inc. | -31.03 Million USD | 96.246% |
| ALR Technologies Inc. | -11.89 Million USD | 90.207% |
| Stratec SE | 14.42 Million USD | 108.076% |
| Vycor Medical, Inc. | -69.69 Thousand USD | -1571.665% |
| Heart Tronics, Inc. | -13.32 Million USD | 91.258% |
| Nu-Med Plus, Inc. | -125.52 Thousand USD | -828.095% |
| Perimeter Medical Imaging AI, Inc. | -14.03 Million USD | 91.7% |
| SANUWAVE Health, Inc. | -25.8 Million USD | 95.486% |
| VMS Rehab Systems, Inc. | 46.44 USD | 2508713.264% |
| Guided Therapeutics, Inc. | -3.48 Million USD | 66.609% |
| Ingen Technologies, Inc. | -5.06 Million USD | 76.983% |
| Odyssey Group International, Inc. | -905.77 Thousand USD | -28.62% |
| United American Healthcare Corporation | 723 Thousand USD | 261.134% |
| ECGI Holdings, Inc. | -3.61 Million USD | 67.737% |
| Capital Group Holdings, Inc. | -658.02 Thousand USD | -77.045% |
| ADM Tronics Unlimited, Inc. | -716.85 Thousand USD | -62.516% |
| Urologix, Inc. | -7.6 Million USD | 84.687% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.69 Million USD | 31.22% |
| Nexeon MedSystems Inc. | -2.17 Million USD | 46.502% |
| SS Innovations International, Inc. | -20.94 Million USD | 94.437% |
| Qualis Innovations, Inc. | -805.02 Thousand USD | -44.717% |
| Smith & Nephew plc | 263 Million USD | 100.443% |
| NIOX Group Plc | 13.64 Million USD | 108.541% |
| Fuse Medical, Inc. | 1.45 Million USD | 179.796% |
| Broncus Holding Corporation | -28.09 Million USD | 95.853% |
| Brain Scientific Inc. | -12.34 Million USD | 90.562% |
| Pressure BioSciences, Inc. | -29.31 Million USD | 96.026% |
| Health Logic Interactive Inc. | -160.24 Thousand USD | -626.998% |